Bristol Myers Squibb (CELG-RI) Payout Ratio (2009 - 2026)

Bristol Myers Squibb (CELG-RI) has reported Payout Ratio for 18 consecutive years, with 0.39 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Payout Ratio fell 59.62% year-over-year to 0.39 in Q2 2026; TTM through Jun 2026 was 0.55, a 43.83% decrease from a year earlier, with the FY2025 full-year figure at 0.71, up 231.34% from the prior year.
• Payout Ratio was 0.39 for Q2 2026 at Bristol Myers Squibb, down from 0.48 in the prior quarter.
• Over five years, Payout Ratio peaked at 16.03 in Q4 2024 and troughed at 0.1 in Q1 2024.
• A 5-year average of 1.46 and a median of 0.6 in 2023 frame the typical range for Payout Ratio.
• Across the five-year window, Payout Ratio jumped 6762.92% in 2023 and tumbled 119.29% in 2024, its largest moves.
• Over 5 years, Payout Ratio stood at 0.57 in 2022, then increased by 16.43% to 0.66 in 2023, then soared by 2334.34% to 16.03 in 2024, then slumped by 92.75% to 1.16 in 2025, then tumbled by 66.6% to 0.39 in 2026.
• The last three Payout Ratio figures came in at 0.39 (Q2 2026), 0.48 (Q1 2026), and 1.16 (Q4 2025), per Business Quant data.